| 前收盘价格 | 30.95 |
| 收盘价格 | 30.76 |
| 成交量 | 687,409 |
| 平均成交量 (3个月) | 554,990 |
| 市值 | 1,418,424,192 |
| 市盈率 (P/E TTM) | 112.15 |
| 价格/销量 (P/S) | 1.26 |
| 股市价格/股市净资产 (P/B) | 1.14 |
| 52周波幅 | |
| 利润日期 | 6 May 2025 |
| 营业毛利率 | 1.13% |
| 营业利益率 (TTM) | 4.49% |
| 稀释每股收益 (EPS TTM) | 0.270 |
| 季度收入增长率 (YOY) | 18.60% |
| 季度盈利增长率 (YOY) | 55.40% |
| 总债务/股东权益 (D/E MRQ) | 30.77% |
| 流动比率 (MRQ) | 1.37 |
| 营业现金流 (OCF TTM) | 187.72 M |
| 杠杆自由现金流 (LFCF TTM) | 146.87 M |
| 资产报酬率 (ROA TTM) | 0.16% |
| 股东权益报酬率 (ROE TTM) | 1.03% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 看跌 |
| Health Information Services (全球的) | 看跌 | 看跌 | |
| 股票 | Omnicell, Inc. | 看跌 | 混合的 |
AIStockmoo 评分
0.6
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.63 |
|
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 1.69% |
| 机构持股比例 | 101.73% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 62.00 (Benchmark, 104.76%) | 购买 |
| 中 | 38.00 (25.50%) | |
| 低 | 36.00 (JP Morgan, 18.89%) | 保留 |
| 平均值 | 45.33 (49.70%) | |
| 总计 | 1 购买, 2 保留 | |
| 平均价格@调整类型 | 36.34 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wells Fargo | 17 Apr 2025 | 38.00 (25.50%) | 保留 | 30.28 |
| JP Morgan | 20 Mar 2025 | 36.00 (18.89%) | 保留 | 34.88 |
| Benchmark | 04 Feb 2025 | 62.00 (104.76%) | 购买 | 43.85 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 14 Apr 2025 | 公告 | Omnicell to Release First Quarter 2025 Financial Results on May 6, 2025 |
| 24 Mar 2025 | 公告 | Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer |
| 12 Mar 2025 | 公告 | Omnicell Announces Chief Financial Officer Transition |
| 06 Feb 2025 | 公告 | Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合